Evaluation of oxidative stress status in children with pervasive developmental disorder and attention deficit hyperactivity disorder using urinary-specific biomarkers

Author： Kawatani Masao   Tsukahara Hirokazu   Mayumi Mitsufumi  

Publisher： Maney Publishing

ISSN： 1743-2928

Source： Redox Report, Vol.16, Iss.1, 2011-01, pp. : 45-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adult Attention Deficit Hyperactivity Disorder

By  

Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 8, 2004-12 ,pp. : 1-7

Guilford Publications Inc

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P.   Keating Gillian M.  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Safety Considerations

By Wolraich Mark L.   McGuinn Laura   Doffing Melissa  

Drug Safety, Vol. 30, Iss. 1, 2007-01 ,pp. : 17-26

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine is a promising treatment for children with attention-deficit hyperactivity disorder

By  

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P.   Keating Gillian M.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite